Replies to post #175 on Oscient Pharmaceuticals Corp.

[$tockfather]

Well .256 will seem real cheap when RAMOPLANIN gets European approval;-)IMO Even with no PR I think we'll see .30's to .40's in days/weeks to come.

GLTA,

Mervini